View Post

Investigational vaccine and immune therapy work well together to fight breast cancer

In In The News by Barbara Jacoby

Source: Duke University Medical Center From: news-medical.net A vaccine for HER2-positive breast cancers that is being tested in a clinical trial at Duke Cancer Institute is part of an effective, two-drug strategy for enlisting the immune system to fight tumors, according to a Duke-led study in Clinical Cancer Research, a journal of the American Association for Cancer Research. The vaccine …